Xylopropamine
Overview of the stimulant drug Xylopropamine
Xylopropamine | |
---|---|
![]() | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | |
PubChem | |
DrugBank | |
ChemSpider | |
KEGG |
Xylopropamine is a stimulant drug that was developed in the mid-20th century. It is chemically related to amphetamines and has been studied for its potential effects on the central nervous system.
Chemical Structure[edit | edit source]
Xylopropamine is a phenethylamine derivative, characterized by its unique chemical structure. The compound consists of a phenyl ring with a propylamine side chain, which is similar to other compounds in the amphetamine class. The presence of a xylo group distinguishes it from other related stimulants.
Pharmacology[edit | edit source]
Xylopropamine acts primarily as a central nervous system stimulant. It is believed to increase the levels of certain neurotransmitters, such as dopamine and norepinephrine, in the brain. This action results in increased alertness, energy, and concentration, similar to the effects of other stimulants like methylphenidate and amphetamine.
Medical Use[edit | edit source]
While Xylopropamine was initially investigated for potential therapeutic uses, such as treating attention deficit hyperactivity disorder (ADHD) and narcolepsy, it has not been widely adopted in clinical practice. The development of other more effective and safer stimulant medications has limited its use.
Side Effects[edit | edit source]
As with other stimulants, Xylopropamine can cause a range of side effects. Common side effects include increased heart rate, elevated blood pressure, insomnia, and anxiety. Long-term use or abuse of stimulants can lead to more serious health issues, including cardiovascular problems and psychological dependence.
Legal Status[edit | edit source]
The legal status of Xylopropamine varies by country. In some jurisdictions, it may be classified as a controlled substance due to its potential for abuse and addiction. It is important to consult local regulations to determine its legal status in a specific area.
Related Compounds[edit | edit source]
Xylopropamine is related to several other stimulant compounds, including:
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD